Capital Bank & Trust CO Astrazeneca PLC Transaction History

Capital Bank & Trust CO

$0
Q3 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $36.2 Million - $39.7 Million	-652,434 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $135,382 - $168,263	2,796 Added 0.43%	652,434 $39.1 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $70,881 - $81,823	-1,503 Reduced 0.23%	649,638 $32.3 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $162,784 - $194,657	-3,355 Reduced 0.51%	651,141 $32.6 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $615,771 - $708,943	-11,603 Reduced 1.74%	654,496 $35.9 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $1.95 Million - $2.5 Million	-45,200 Reduced 6.35%	666,099 $35.2 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $189,290 - $257,111	5,009 Added 0.71%	711,299 $31.8 Million
Q4 2019 Feb 18, 2020	SELL	$42.46 - $50.46 $689,975 - $819,975	-16,250 Reduced 2.25%	706,290 $35.2 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $35.4 Million - $40.1 Million	-881,418 Reduced 54.95%	722,540 $32.2 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $1.78 Million - $1.99 Million	-47,681 Reduced 2.89%	1,603,958 $66 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $1.43 Million - $1.73 Million	40,277 Added 2.5%	1,651,639 $68.9 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $4.47 Million - $5.03 Million	-121,254 Reduced 7.0%	1,611,362 $61.2 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $1.27 Million - $1.45 Million	36,451 Added 2.15%	1,732,616 $68.6 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $2.05 Million - $2.2 Million	-59,452 Reduced 3.39%	1,696,165 $59.6 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $1.47 Million - $1.63 Million	44,516 Added 2.6%	1,755,617 $61.4 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $32.7 Million - $35.4 Million	-1,019,107 Reduced 37.33%	1,711,101 $59.4 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $1.66 Million - $1.95 Million	57,353 Added 2.15%	2,730,208 $92.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,672,855	2,672,855 $91.1 Million

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

Price T Rowe Associates Inc Baltimore, MD

64.9M
Shares

$5.06 Billion
0.61% of portfolio
Primecap Management CO Pasadena, CA

42.6M
Shares

$3.32 Billion
2.44% of portfolio
Wellington Management Group LLP Boston, MA

40.6M
Shares

$3.16 Billion
0.58% of portfolio
Capital International Investors Los Angeles, CA

36.7M
Shares

$2.86 Billion
0.6% of portfolio
Franklin Resources Inc San Mateo, CA

17.6M
Shares

$1.37 Billion
0.44% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.

Account